|
|
|
Company
Name |
Short
Summary |
| Adaptive BioTechnologies |
Adaptive BioTechnologies is focused on the commercialization of measuring adaptive immunity, through massive parallel sequencing of T cell receptors. |
| Amgen |
Amgen
develops therapeutic proteins in oncology/hematopoiesis,
inflammation, and neurobiology/endocrinology. |
| Bayer |
Bayer develops and markets various
drugs and chemicals. |
| Calistoga Pharmaceuticals |
Calistoga Pharmaceuticals is focused on the research and development of products for treatment of patients with cancer and inflammatory diseases. |
| Cell
Therapeutics |
CTI
is committed to developing, acquiring, and commercializing
innovative treatments for cancer. |
| CompleGen |
CompleGen is focused on the discovery, development, and application of a process for gene replacement in yeast. |
| Coronado Biosciences |
Coronado Biosciences is focused on research and development of in-licensed cancer therapies. |
| Dendreon
|
Dendreon
is a focused on the development of targeted therapies
for the treatment of cancer. The Company's innovative
approaches include therapeutic vaccines, monoclonal
antibodies and small molecule product candidates. |
| Gilead
Sciences |
Gilead
has a broad-based focus in infectious disease,
including antivirals, antifungals and antibiotics,
as well as a specialized focus in oncology. |
| HemaQuest Pharmaceuticals |
HemaQuest Pharmaceuticals is focused on the development of small molecule drugs for treatment of hematologic disorders. |
| Immune Design |
Immune Design is focused on the research and development of lentivirus vaccines and adjuvanted vaccines. |
| Impel NeuroPharma |
Impel NeuroPharma is focused on the research and development of a technology platform for nose-to-brain drug delivery. |
| Kineta |
Kineta is focused on discovery, research and development of broad spectrum antiviral therapies for the treatment of RNA viruses. |
| LifeSpan
Biosciences |
LifeSpan
BioSciences provides tools and services to help
their customers correlate genes and diseases. |
| Oncothyreon |
Oncothyreon is focused on the research, development, and commercialization of vaccines and small molecules to treat a variety of cancer indications. |
| Pacific Biomarkers |
Pacific Biomarkers is focused on providing biomarker laboratory services to support therapeutic and diagnostic development. |
| PhaseRx |
PhaseRx is an focused on the research and development of a polym-based RNAi delivery technology. |
| Poniard Pharmaceuticals |
Poniard Pharmaceuticals is focused on the development and commercialization of small molecule products for the treatment of cancer. |
| PPD |
PPD is focused on drug discovery, development and lifecycle management services to companies in the pharmaceutical, biotechnology, medical device industries. |
| ProFibrix |
ProFibrix is focused on the research and develoment of fibrinogen products for the hemostasis and regenerative medicine markets. |
| St. Jude Medical |
St. Jude Medical is focused on the development and commercialization of medical devices for use in the treatments of cardiac, neurological and chronic pain patients. |
| TapImmune |
TapImmune is focused on the development of therapeutics and vaccines in oncology and infectious disease. |
| Targeted
Genetics |
Targeted
Genetics Corporation is at the forefront of the
rapidly advancing field of gene therapy, initially
developing products for the treatment of cystic
fibrosis, cancer and infectious diseases. |
| Theraclone Sciences |
Theraclone Sciences is focused on the discovery, research, and development of therapeutic antibodies for the treatment of infectious disease and inflammation. |
| Trubion Pharmaceuticals |
Trubion Pharmaceuticals is focused on research and development of protein therapeutics to treat autoimmune and inflammatory diseases and cancer. |
| VentiRx Pharmaceuticals |
VentiRx Pharmaceuticals is focused on Toll-like receptor 8 (TLR8) therapeutics for the treatment of cancer, respiratory, and autoimmune diseases. |
| VLST |
VLST is focused on the research and development of immunotherapeutic approaches to treat patients with cancer and autoimmune disorders. |
| ZymoGenetics |
ZymoGenetics
is focused on the discovery, development, and
commercialization of therapeutic proteins. |
